FDA Eases Access to Unapproved Cancer Drugs - OBR Daily

FDA Eases Access to Unapproved Cancer Drugs

By Christina Bennett, MS

"Patients with cancer are treated with drugs already approved by the U.S. Food and Drug Administration (FDA) or with an investigational agent in a clinical trial. But there are some patients who may need access to investigational drugs outside the realm of a clinical trial..."

Read more about how Project Faciliate and the Foundation are working together to simplify the expanded access process: http://obroncology.com/article/fda-eases-access-to-unapproved-cancer-drugs/